TrialBMC cancer2010

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.

Milind M Javle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.